China’s 2026 National Reimbursement Drug List Negotiations Set for Sept 5

TREE NEWS update: Multiple drugmakers said the negotiation and bidding for China’s 2026 National Reimbursement Drug List (NRDL), along with price consultations for the commercial insurance innovative drug catalog, will commence on September 5 at the National People’s Congress Conference Center. The National Healthcare Security Administration completed pre-communication with negotiating companies last week. Industry insiders expect the on-site negotiations and price consultations to last four to five days.